APP and Alzheimer disease: DDB and DNLAs also ameliorate amyloidogenic APP processing and tau hyperphosphorylation and eventually prevent hippocampal dendritic spine degeneration of 3 × Tg-AD mice, as well as up-regulate synaptic protein expression.